The effects of 5,7-dihydroxytryptamine-induced lesions of the ascending 5-hydroxytryptamine pathways on the sleep wakefulness cycle.
D000344:Afferent Pathways; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002540:Cerebral Cortex / Q000378:metabolism; D002997:Clomipramine / Q000494:pharmacology; D004569:Electroencephalography; D004576:Electromyography; D008297:Male; D009638:Norepinephrine / Q000378:metabolism / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D012702:Serotonin Antagonists; D012890:Sleep / Q000502:physiology*; D014851:Wakefulness
D012702:Serotonin Antagonists; D012701:Serotonin; D002997:Clomipramine; D009638:Norepinephrine